311C90 (Zolmitriptan *), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: A comparison of its absorption during a migraine attack and in a migraine-free period

Cephalalgia

Volumn 16, Issue 4, 1996, Pages 270-275

  Thomsen, L L ^a,c   Dixon, R ^b   Lassen, L H ^a   Gibbens, M ^b   Langemark, M ^a   Bendtsen, L ^a   Daugaard, D ^a   Olesen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

311C90; Efficacy; Migraine; Oral absorption; Safety

Indexed keywords

SEROTONIN AGONIST; ZOLMITRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; MIGRAINE; ORAL DRUG ADMINISTRATION; PARESTHESIA; RECURRENT DISEASE; SOMNOLENCE; THORAX PAIN;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLES; OXAZOLIDINONES; RECURRENCE; SEROTONIN AGONISTS; TIME FACTORS; TRYPTAMINES;

EID: 0029895799     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1604270.x     Document Type: Article

References (10)

1. 1D receptor partial agonist for the acute treatment of migraine. Headache 1994;34 (abstract)
2. Goadsby PJ, Edvinsson L. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache 1994;34:394-9
3. Peck R, Dixon R, Seaber E, On N, Mercer J, Posner J, Roland PE. Clinical pharmacology of 311C90. In: Clifford Rose F, editor. New advances in headache research, vol. 4. 1994;9-10
4. Dahlof C, Diener HC, Goadsby PJ, Massiou H, Olesen J, Schoenen J, Wilkinson M, Sweet RM, Klein KB. A multicenter, double-blind, placebo-controlled, dose-ranging study to investigate the efficacy and safety of oral doses of 311C90 in the acute treatment of migraine. Headache 1995;35:292 (abstract)
5. The Oral Sumatriptan Dose Defining Study Group. Sumatriptan - an oral dose-defining study. Eur Neurol 1991;31:300-5
6. The Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991;31:306-13
7. Tokola RA, Neuvonen PJ. Effect of migraine attacks on paracetamol absorption. Br J Clin Pharmacol 1984;18:867-1
8. Cutler NR, Hussey EK, Sramek JJ, Clements BD, Paulsgrove LA, Busch MA, Donn KH. Oral sumatriptan pharmacokinetics in the migrainous state (abstract). Cephalalgia 1991;11 Suppl 11:222
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and fascial pain. Cephalalgia 1988;8 Suppl 7:19-28
10. 1D agonist in the acute oral treatment of migraine; a double-blind, placebo-controlled dose-range finding study. Neurology 1995;46:1-5